Cocaine enhances susceptibility to endotoxemic shock in a subset of rats

Critical Care Medicine

Volumn 32, Issue 1, 2004, Pages 175-183

  Knuepfer, Mark M ^a   Bloodgood, Tracy A ^a   Matuschak, George M ^a   Lechner, Andrew J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac output; Cocaine; Endotoxemia; Hemodynamics; Lipopolysaccharide; Population differences; Sympathetic nervous system; Systemic vascular resistance

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BACTERIUM LIPOPOLYSACCHARIDE; COCAINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PRAZOSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DISEASE PREDISPOSITION; DOSE RESPONSE; ENDOTOXEMIA; ESCHERICHIA COLI; EXPERIMENTAL RAT; HEART OUTPUT; HEMODYNAMICS; INFLAMMATION; LETHALITY; MYDRIASIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PUPIL; RAT; RECORDING; SEROTYPE; SHOCK; SURVIVAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 1642533571     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000104202.81041.4B     Document Type: Article

References (56)

1. Baldwin GC, Tashkin DP, Buckley DM, et al: Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med 1997; 156:1606-1613
2. Di Francesco P, Marini S, Pica F, et al: In vivo cocaine administration influences lymphokine production and humoral immune response. Immunologic Res 1992; 11:74-79
3. Ruiz P, Cleary T, Nassiri M, et al: Human T lymphocyte subpopulation and NK cell alterations in persons exposed to cocaine. Clin Immunol Immunopathol 1994; 70:245-250
4. Wang Y, Huang DS, Watson RR: In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci 1994; 54:401-411
5. Xu W, Bai F, Tummalapalli CM, et al: The interactive effects of cocaine/gender on immune function in mice: An observation of in vivo acute cocaine exposure. Int J Immunopharmacol 1997; 19:333-340
6. Bagasra O, Forman L: Functional analysis of lymphocytes subpopulations in experimental cocaine abuse: I. Dose-dependent activation of lymphocyte subsets. Clin Exp Immunol 1989; 77:289-293
7. De la Fuente JC, DeVane CL: Immunologic effects of cocaine and related alkaloids. Immunopharmacol Immunotoxicol 1991; 13:11-23
8. Isner JM, Estes NA, Thompson PD, et al: Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315:1438-1443
9. Lange RA, Cigarroa RG, Yancy CW Jr, et al: Cocaine-induced coronary artery vasoconstriction New Engl J Med 1989; 321:1557-1562
10. Minor RL Jr, Scott BD, Brown DD, et al: Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991; 115:797-806
11. Lora-Tamayo C, Tena T, Rodriquez A: Cocaine-related deaths. J Chromatog A 1994; 674:217-224
12. Nishijima H, Weil MH, Shubin H, et al: Hemodynamic and metabolic studies on shock associated with Gram-negative bacteremia. Medicine 1973; 52:287-294
13. Cacioppo JT, Berntson GG, Malarkey WB, et al: Autonomic, neuroendocrine, and immune responses to psychological stress: The reactivity hypothesis. Ann NY Acad Sci 1998; 840:664-673
14. Branch CA, Knuepfer MM: Causes of differential cardiovascular sensitivity to cocaine: I. Studies in conscious rats. J Pharmacol Exp Ther 1994; 269:674-683
15. Knuepfer MM, Mueller PJ: A model of cocaine-induced cardiotoxicity. Pharmacol Biochem Behav 1999; 63:489-500
16. Knuepfer MM, Branch CA, Gan Q, et al: Relationship between cocaine-induced cardiac ultrastructural alterations and cardiac output responses in rats. Exp Mol Pathol 1993; 59:155-168
17. Lechner AJ, Velasquez A, Knudsen KR, et al: Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 1998; 157:1550-1558
18. Matuschak GM, Munoz CF, Johanns CA, et al: Upregulation of postbacteremic TNF-α and IL-1α gene expression by alveolar hypoxia/reoxygenation in perfused rat lungs. Am J Respir Crit Care Med 1998; 157:629-637
19. Baldwin GC, Roth MD, Tashkin DP: Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 1998; 83:133-138
20. Pelligrino T, Bayer BM: In vivo effects of cocaine on immune cell function. J Neuroimmunol 1998; 83:139-147
21. Phillips DL, Tebett IR, Masten S, et al: Stimulatory effects of cocaine and its metabolites on IM-9 human B-lymphoblastoid cells. Int J Immunopharmacol 1995; 17:57-63
22. Poet TS, Pillai R, Wood S, et al: Stimulation of natural killer cell activity by murine retroviral infection and cocaine. Toxicol Lett 1991; 59:147-152
23. Van Dyke C, Stesin A, Jones R, et al: Cocaine increases natural killer cell activity. J Clin Invest 1986; 77:1387-1390
24. Blatteis CM, Hales JRS, Fawcett AA, et al: Fever and regional blood flows in wethers and parturient ewes. J App Physiol 1988; 65:165-172
25. Brackett DJ, Schaefer CF, Tompkins P, et al: Evaluation of cardiac output, total peripheral resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circul Shock 1985; 17:273-284
26. Klemm K, Moody FG: Regional intestinal blood flow and nitric oxide synthase inhibition during sepsis in the rat. Ann Surg 1998; 227:126-133
27. Branch CA, Knuepfer MM: Causes of differential cardiovascular sensitivity to cocaine: II. Sympathetic metabolic and cardiac effects. J Pharmacol Exp Ther 1994; 271:1103-1113
28. Purcell RM, Gan Q, Knuepfer MM: Variable renal sympathetic responses to cocaine in rats. Abstr. FASEB J 2001; 15:A801
29. Rivier C, Vale W: Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res 1987; 422:403-406
30. Stanulis ED, Matulka RA, Jordan SD, et al: Role of corticosterone in the enhancement of the antibody response after acute cocaine administration. J Pharmacol Exp Ther 1997; 280:284-291
31. De Luigi A, Terreni L, Sironi M, et al: The sympathetic nervous system tonically inhibits peripheral interleukin-1β and interleukin-6 induction by central lipopolysaccharide. Neuroscience 1998; 83:1245-1250
32. Felten SY, Madden KS, Bellinger DL, et al: The role of the sympathetic nervous system in the modulation of immune responses. Adv Pharmacol 1998; 42:583-587
33. Felten DL, Felten SY, Bellinger DL, et al: Noradrenergic and peptidergic innervation of secondary lymphoid organs: Role in experimental rheumatoid arthritis. Eur J Clin Invest 1992; 22:37-41
34. Friedman EM, Irwin MR: Modulation of immune cell function by the autonomic nervous system. Pharmacol Ther 1997; 74:27-38
35. Madden KS, Sanders VM, Felten DL: Catecholamine influences and sympathetic neural modulation of immune responsiveness. Ann Rev Pharmacol Toxicol 1995; 17-48
36. Vizi ES, Orso E, Osipenko ON, et al: Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 1995; 68: 1263-1276
37. Williams JM, Felten DL: Sympathetic innervation of murine thymus and spleen: A comparative histoflourescence study. Anat Rec 1981; 199:531-542
38. 2-adrenergic, spleen-dependent process. Am J Physiol 1990; 258:E191-E202
39. Williams LT, Snyderman R, Lefkowitz RJ: Identification of β-adrenergic receptors in human lymphocytes by (-) [3H]alprenolol binding. J Clin Invest 1976; 57:149-155
40. 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits. Brain Res 1995; 705:302-306
41. Elenkov IJ, Papanicolaou DA, Wilder RL, et al: Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc Assoc Am Physicians 1996; 108:374-381
42. 2-adrenoceptors on plasma levels of tumour necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J Endocrinol 1995; 144:457-462
43. Elenkov IJ, Hasko G, Kovacs KJ, et al: Modulation of lipopolysaccharide- induced tumor necrosis factor-α production by selective α-and β-adrenergic drugs in mice. J Neuroimmunol 1995; 61:123-131
44. 2-adrenoceptor subtype. Am J Respir Cell Mol Biol 1998; 19:400-407
45. Kannan H, Tanaka Y, Kunitake T, et al: Activation of sympathetic outflow by recombinant human interleukin-1β in conscious rats. Am J Physiol 1996; 270:R479-R485
46. Niijima A, Hori T, Aou A, et al: The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Autonom Nerv Syst 1991; 36:183-192
47. Zhou ZZ, Wurster RD, Qi M, et al: Sympathoadrenal activation in sinoaortic-denervated rats following endotoxin. Am J Physiol 1991; 260:R739-R746
48. Qiu Y, Peng T, Wang J: Immunoregulatory role of neurotransmitters. Adv Neuroimmunol 1996; 6:223-231
49. Knuepfer, MM: Cardiovascular disorders associated with cocaine use: Myths and truths. Pharmacol Ther 2003; 97:181-222
50. Tella SR, Schindler CW, Goldberg SR: Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats. J Pharmacol Exp Ther 1992; 262:936-946
51. Guo A-L, Petraglia F, Criscuolo M, et al: Adrenergic and serotonergic receptors mediate the immunological activation of corticosterone secretion in male rats. Gynecol Endocrinol 1996; 10:149-154
52. Tobias PS, Mathison J, Mintz D, et al: Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 1992; 7:239-245
53. Matuschak GM, Lechner AJ: Hepatic regulation of systemic host defense and its derangement in multiple systems organ dysfunction and failure. In: Multiple Systems Organ Failure. Matuschak GM (Ed). Marcel-Dekker, 1993, pp 1-38
54. Matuschak GM, Munoz C, Epperly NA, et al: TNF-α and IL-6 expression in perfused rat liver after intraportal candidemia vs. E. coli or S. aureus bacteremia. Am J Physiol 1994; R446-R454
55. Wiles JB, Cerra FB, Siegel JH, et al: The systemic septic response: Does the organism matter? Crit Care Med 1980; 8:55-60
56. Knuepfer MM, Gan Q, Muller JR, et al: Hemodynamic response variability to behavioral stress correlates with predisposition to disease. In: Stress: Neural, Endocrine and Molecular Studies. McCarty R, Aguilera G, Sabban E, Kvetnansky R (Eds). Gordon and Breach Science, 2002, pp 71-75